
Nepafenac (0.1% w/v)
Active composition
Nepafenac is converted to its active form in the eye, where it inhibits cyclooxygenase enzymes, reducing the synthesis of inflammatory mediators.
Medical applications
Nepacin Eye Drop, containing 0.1% w/v Nepafenac, is a prescription ophthalmic solution indicated for the management of ocular inflammation following cataract surgery. Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis, thereby reducing inflammation, pain, and ocular hyperemia. This medication is intended for topical use in the affected eye(s) and should be administered 3 times daily, starting 1 day prior to cataract surgery and continuing for 28 days post-surgery. Nepacin Eye Drop helps promote a more comfortable and expedient recovery from cataract surgery by reducing inflammation and minimizing post-operative pain. It is essential to follow the prescribed regimen and consult with an ophthalmologist for proper use and dosage.
Benzophenone Derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nepacin Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Nepacin Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Nepacin Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nepacin Eye Drop

Nepafenac (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Nepafenac is converted to its active form in the eye, where it inhibits cyclooxygenase enzymes, reducing the synthesis of inflammatory mediators.
Medical applications
Nepacin Eye Drop, containing 0.1% w/v Nepafenac, is a prescription ophthalmic solution indicated for the management of ocular inflammation following cataract surgery. Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis, thereby reducing inflammation, pain, and ocular hyperemia. This medication is intended for topical use in the affected eye(s) and should be administered 3 times daily, starting 1 day prior to cataract surgery and continuing for 28 days post-surgery. Nepacin Eye Drop helps promote a more comfortable and expedient recovery from cataract surgery by reducing inflammation and minimizing post-operative pain. It is essential to follow the prescribed regimen and consult with an ophthalmologist for proper use and dosage.
Benzophenone Derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nepacin Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Nepacin Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Nepacin Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nepacin Eye Drop















